- Home
- CCTSU vs LSB Comparison
CCTSU vs LSB Comparison
Compare CCTSU & LSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCTSU
- LSB
- Stock Information
- Founded
- CCTSU N/A
- LSB 2002
- Country
- CCTSU
- LSB China
- Employees
- CCTSU N/A
- LSB 758
- Industry
- CCTSU
- LSB
- Sector
- CCTSU
- LSB
- Exchange
- CCTSU NYSE
- LSB NYSE
- Market Cap
- CCTSU N/A
- LSB 72.7M
- IPO Year
- CCTSU N/A
- LSB N/A
- Fundamental
- Price
- CCTSU $11.49
- LSB $3.86
- Analyst Decision
- CCTSU
- LSB
- Analyst Count
- CCTSU 0
- LSB 0
- Target Price
- CCTSU N/A
- LSB N/A
- AVG Volume (30 Days)
- CCTSU N/A
- LSB 130.1K
- Earning Date
- CCTSU N/A
- LSB 10-18-2024
- Dividend Yield
- CCTSU N/A
- LSB N/A
- EPS Growth
- CCTSU N/A
- LSB N/A
- EPS
- CCTSU N/A
- LSB N/A
- Revenue
- CCTSU N/A
- LSB $79,415,311.00
- Revenue This Year
- CCTSU N/A
- LSB $39.33
- Revenue Next Year
- CCTSU N/A
- LSB $75.61
- P/E Ratio
- CCTSU N/A
- LSB N/A
- Revenue Growth
- CCTSU N/A
- LSB N/A
- 52 Week Low
- CCTSU N/A
- LSB $3.20
- 52 Week High
- CCTSU N/A
- LSB $11.20
- Technical
- Relative Strength Index (RSI)
- CCTSU 67.98
- LSB 33.86
- Support Level
- CCTSU $11.21
- LSB $3.20
- Resistance Level
- CCTSU $11.58
- LSB $8.60
- Average True Range (ATR)
- CCTSU 0.00
- LSB 0.78
- MACD
- CCTSU 0.02
- LSB -0.52
- Stochastic Oscillator
- CCTSU 100.00
- LSB 11.67
About CCTSU CACTUS ACQUISITION CORP 1 LIMITED UNIT 1 CL A & 1/2 RED WT EXP(17/08/2028)
Cactus Acquisition Corp 1 Ltd is a blank check company.
About LSB LAKESHORE BIOPHARMA CO LTD
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.